Company Update (NYSE:EL): The Estée Lauder Companies Announces Key Strategic Appointments to Further Expand Capabilities in Digital and Consumer Engagement, and Continue Strengthening Communications Globally

[Business Wire] – The Estée Lauder Companies Inc. announced two key strategic appointments today that will help further expand the Company’s capabilities in consumer engagement and digital Read more on this. The Estée Lauder Companies Inc. (EL) , with a current market cap of $34.89B, started trading this morning at $96.04. Today, shares have traded between $94.62 and $96.25 per share with the price of the stock fluctuating between $73.67 to $97.33 over the last 52 weeks. EL shares are currently priced at 30.66x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 18.10x earnings multiple for the same period. The company pays shareholders $1.20 per share annually in dividends, yielding 1.24%. Consensus earnings for the current quarter by the 21 sell-side analysts covering the stock is an estimate of $0.61 per share, which would be $0.11 worse than the year-ago quarter and a $0.15 sequential decrease. Furthermore, our analysis shows the full-year EPS estimate to be $3.15, which would be a $0.33 better when compared to the last year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $2.65 Billion. If reported, that would be a 2.71% increase over the year-ago quarter. More recently, Goldman downgraded EL from Buy to Neutral (Mar 16, 2016). Previously, Atlantic Equities Initiated EL at to Overweight. Investors should keep in mind is that the average price target is $101.67, which is 5.86% above where the stock opened this morning. See more in (NYSE:EL) Similar Articles: Company Update: The Est (NYSE:EL) – The Estée Lauder Companies Inc. Acquires By Kilian Company Update (NYSE:EL): The Estée Lauder Companies Delivers Strong Sales and Earnings Growth in Fiscal 2016 Second Quarter Stock Update (NYSE:EL): The Estée Lauder Companies Completes Investment in Dr. Jart+